Revenue grew 18% year-over-year to ₹1,20,009 lakhs, with net profit up 21% and EBITDA margin at 42.1%. Major investments included a new injectable facility, US and renewable energy ventures, and expanded global presence. The company remains debt-free, with a proposed dividend of ₹10.70 per share.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.